Tamsulosin hydrochloride INN 0.4mg/capsule. 20's pack: 200.83 MRP4 Pcs Capsule: 41.00 MRPIndication:Treatment of the signs and symptoms of Benign Prostatic Hyperplasia (BPH).Dosage & Administration:1(one) capsule once daily.Preparation:Maxrin® Capsule : Each box contains 30 capsules in bli..
Norethisterone 5mg/tablet. 5mg x 30's pack: 150.00 MRPIndication:Dysfunctional Uterine Bleeding (DUB), Premenstrual Syndrome (PMS), Endometriosis, Dysmenorrhea and Postponement of menstruation.Dosage & Administration:• Dysfunctional Uterine Bleeding (DUB): 1 tablet 3 times a day for 3-4 cycles from ..
Betahistine mesylate INN 6mg/tabletInd; C/I; S/E; Cautions: See above under thetext.Dosage & admin: The usual initial dose is 6mg to 12mg 3 times daily taken preferably after meals. The dosage may be adjusted depending on the patient's age and symptoms. Maintenance dosage may be given up to 36mg dai..
Nimodipine BP 30mg/tablet (f.c). 30's pack: 150.30 MRP10 Pcs Tablet: 50.00 MRPIndication:For the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their pos..
Zolmitriptan INN 2.5mg/tablet 12's pack: 301.20 MRP.Indication:Acute treatment of migraine with or without aura in adults.Dosage & Administration:The initial recommended dose is 2.5 mg. If symptoms persist or return within 24 hours, a second dose has been shown to be effective but should not be take..
Indication:Emergency ContraceptionDosage & Administration:The tablet must be taken as soon as possible within 72 hours (3 days) after unprotected intercourse or a known or suspected contraceptive failure. The tablet can be taken with or without food. If vomiting occurs within 3 hours of NorpillTM1 i..
Ondansetron hydrochloride BP equivalent to ondansetron 16mg/suppository.16mg x 10's pack: 200.00 MRPIndicationsOndansetron is indicated for: Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapyPrevention of nausea and vomiting associated with radiotherapyPreve..
Indication:1. Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy.2. Prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.3. Prevention of nausea and vomiting associated with radiotherapy4. Preve..